France Dental Fluoride Treatment Market Analysis

France Dental Fluoride Treatment Market Executive Summary

The France Dental Fluoride Treatment Market is at around $417.1 Mn in 2023 and is projected to reach $509.5 Mn in 2030, exhibiting a CAGR of 2.9% during the forecast period 2023-2030.

Dental hygienists and dentists professionally apply high-concentration fluoride products to teeth in order to build enamel and prevent tooth decay. This procedure is known as a dental fluoride treatment. During routine dental appointments, they are usually applied as a gel, foam, varnish, or solution. Fluoride fortifies enamel and increases teeth's resistance to bacterial acid attacks by enhancing the absorption of minerals like calcium and phosphate. It also inhibits the growth of cavity-causing bacteria, slowing or stopping their destructive effects. Fluoride is a valuable tool in the fight against tooth decay and enamel deterioration.

Many advantages come with fluoride treatments: they can delay the need for dental work, prevent gum disease and tooth pain, extend the life of infant teeth, slow the growth of existing cavities, reduce the risk of cavities by around 25%, and delay the need for dental repair. In accordance with an individual's risk of cavities, the American Dental Association suggests getting professional fluoride treatments every 3, 6, or 12 months. Fluoride toothpaste for children aged three and over should be applied in a pea-sized smear, but only in little smears for younger children.

Temporary tooth discolouration or staining, discomfort, and in rare instances, allergic reactions are possible adverse effects. Too much fluoride can cause fluorosis, which is characterized by white streaks or other discolorations on teeth, especially in young children. The modest quantities of fluoride in over-the-counter products make it extremely difficult to attain harmful levels. Acute toxicity from taking too many fluoride supplements can result in fatigue, increased sweating, nausea, diarrhea, and in extreme situations, even death.

According to WHO report, prevalence of dental caries in children in France is high, with 56% of children caries-free at 12 years and prevalence of periodontal disease in adults is also high, with approximately 80% of subjects aged 35-64 years having periodontal disease. The market therefore is driven by significant factors like growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, cosmetic dentistry boom, technological advancements etc.

Some of the major players operating in the France dental fluoride treatment market are Pierre Fabre Oral Care, GUM, Biotech Dental, 3M, Colgate and others.

Market Dynamics

Market Drivers

Rising incidence of dental disorders: The prevalence of dental caries and other oral health issues like gum disease has been increasing in France. According to WHO report, prevalence of dental caries in children in France is high, with 56% of children caries-free at 12 years and prevalence of periodontal disease in adults is also high, with approximately 80% of subjects aged 35-64 years having periodontal disease, thus the rise in oral disorder is, driving the demand for effective preventive treatments like fluoride applications.

Favourable reimbursement policies: The French healthcare system provides coverage for some basic dental services, including certain fluoride treatments, for specific population groups like children. This availability of public insurance reimbursement is promoting the adoption of fluoride treatments.

Increasing awareness about oral health: Awareness campaigns by the government and dental associations are helping educate the French population about the importance of preventive dental care and the benefits of fluoride treatments in maintaining good oral health.

Market Restraints

Safety concerns: There are some safety concerns around the use of fluoride, especially in high concentrations, which has led to hesitancy and resistance among certain patients and communities in France. Perceptions about potential risks can restrain market growth.

Access to dental care: While the French healthcare system covers basic dental services for certain groups, access to comprehensive dental care, including fluoride treatments, may not be uniform across all regions of the country. Disparities in access can limit the market potential.

Competition from alternative products: The availability of over-the-counter fluoride products like toothpaste and mouthwash presents a restraint, as patients may opt for these alternatives, reducing the perceived need for professional fluoride treatments.

Regulatory Landscape and Reimbursement Scenario

In France, the regulatory body for pharmaceuticals is the French National Agency for Medicines and Health Products Safety (ANSM), which is responsible for the regulation, assessment, and monitoring of health products, including medicines and medical devices. The ANSM authorizes certain clinical trials and clinical investigations for medical devices and issues national marketing authorisations for medicines. The High Health Authority (HAS) is the French health technology assessment (HTA) body responsible for the evaluation of medicines and medical devices with a view to pricing and reimbursement decision-making. The Economic Committee for Medicinal Products (CEPS) determines the prices of reimbursed medicinal products and medical devices based on the outcome of the HAS assessment.

The pricing and reimbursement landscape in France is complex and involves multiple pathways and coverage by the healthcare system. The constant is that market access in France relies on a value-based approach. There are five different early-access programs, each with its own specific rules. After marketing authorisation, access to the standard reimbursed market requires prior inclusion on a positive reimbursement list, of which there are four in France. The price of medicinal products covered through early access or standard coverage may be regulated differently, such as progressive and final rebates, surcharge rebates for early-access programs, and for standard coverage, rebates, pharmaceutical contributions, price decreasing, etc.

Competitive Landscape

Key Players

Here are some of the major key players in the France Dental Fluoride Treatment Market:

• Pierre Fabre Oral Care
• GUM
• Philips
• Elgydium
• Biotech Dental
• 3M
• Colgate
• Carestream Dental
• Periosystem
• Unileiver